Rheumatoid factors: Clinical applications

274Citations
Citations of this article
684Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects. Rheumatoid factors form part of the workup for the differential diagnosis of arthropathies. In clinical practice, it is recommended to measure anti-cyclic citrullinated peptide antibodies and rheumatoid factors together because anti-cyclic citrullinated peptide antibodies alone are only moderately sensitive, and the combination of the two markers improves diagnostic accuracy, especially in the case of early rheumatoid arthritis. Furthermore, different rheumatoid factor isotypes alone or in combination can be helpful when managing rheumatoid arthritis patients, from the time of diagnosis until deciding on the choice of therapeutic strategy. Copyright © 2013 Francesca Ingegnoli et al.

Cite

CITATION STYLE

APA

Ingegnoli, F., Castelli, R., & Gualtierotti, R. (2013). Rheumatoid factors: Clinical applications. Disease Markers. Hindawi Limited. https://doi.org/10.1155/2013/726598

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free